HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Inoue Selected Research

FLB 457

1/2006Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.
3/2004Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.
1/2002Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Inoue Research Topics

Disease

26Neoplasms (Cancer)
12/2020 - 02/2002
24Retinal Perforations
03/2022 - 02/2002
20Retinal Detachment (Retinal Detachments)
11/2021 - 02/2002
18Inflammation (Inflammations)
01/2022 - 08/2005
15Neuralgia (Stump Neuralgia)
08/2015 - 03/2003
13Macular Degeneration (Age-Related Maculopathy)
11/2021 - 01/2007
13Epiretinal Membrane (Epiretinal Membranes)
01/2021 - 02/2002
13Infections
01/2021 - 06/2003
11Macular Edema
10/2022 - 02/2004
11Diabetic Retinopathy (Retinopathy, Diabetic)
06/2016 - 05/2003
11Pain (Aches)
01/2010 - 05/2003
9Multiple Sclerosis
01/2022 - 05/2012
9Wounds and Injuries (Trauma)
01/2021 - 05/2002
9Hyperalgesia
08/2015 - 03/2003
9Ischemia
01/2015 - 04/2003
8Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 05/2012
7Rheumatoid Arthritis
07/2022 - 06/2004
7Retinoschisis (Retinoschisis, Juvenile)
06/2022 - 11/2008
7Obesity
10/2021 - 01/2011
7Vitreous Detachment (Posterior Vitreous Detachment)
07/2021 - 02/2007
7Cataract (Cataracts)
01/2020 - 11/2004
6Hemorrhage
09/2021 - 11/2005
6Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2007
6Endophthalmitis (Ophthalmia)
01/2020 - 01/2008
6Choroidal Neovascularization
02/2010 - 10/2006
5Colonic Neoplasms (Colon Cancer)
12/2020 - 03/2014
5Renal Insufficiency (Renal Failure)
01/2014 - 05/2002
5Neoplasm Metastasis (Metastasis)
08/2011 - 05/2002
5Atherosclerosis
09/2007 - 07/2002
5Schizophrenia (Dementia Praecox)
01/2006 - 01/2002
4Aspiration Pneumonia
11/2020 - 01/2015
4Edema (Dropsy)
01/2020 - 04/2006
4Vitreous Hemorrhage
09/2015 - 08/2010
4Hypersensitivity (Allergy)
06/2014 - 08/2006
4Uveitis
01/2007 - 08/2005
4Experimental Melanoma
07/2002 - 04/2002
3Retinal Vein Occlusion
10/2022 - 07/2021
3Stroke (Strokes)
05/2022 - 04/2003
3Cough
01/2022 - 09/2013
3Melanoma (Melanoma, Malignant)
01/2022 - 02/2008
3Deglutition Disorders (Dysphagia)
01/2021 - 01/2015
3Osteoporosis
10/2019 - 01/2012
3Myopia
12/2018 - 02/2002
3Type 2 Diabetes Mellitus (MODY)
02/2018 - 08/2007
3Carcinogenesis
01/2018 - 02/2003
3Neovascular Glaucoma
09/2015 - 01/2008
3Glaucoma
01/2015 - 01/2008
3Nephrotic Syndrome (Syndrome, Nephrotic)
01/2015 - 08/2008
3Ganglion Cysts (Ganglion)
01/2015 - 08/2006
3Acute Kidney Injury (Acute Renal Failure)
06/2012 - 09/2007

Drug/Important Bio-Agent (IBA)

34Retinaldehyde (Retinal)IBA
11/2021 - 02/2002
23Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2003
7CytokinesIBA
01/2022 - 06/2004
7VaccinesIBA
01/2021 - 04/2007
6InflammasomesIBA
01/2022 - 06/2012
6Messenger RNA (mRNA)IBA
01/2017 - 12/2004
6SteroidsIBA
09/2013 - 09/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 06/2007
5Capsaicin (Zostrix)FDA Link
11/2020 - 03/2003
5AntigensIBA
03/2016 - 03/2002
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2013 - 04/2006
5Pharmaceutical PreparationsIBA
09/2011 - 01/2002
5lysophosphatidic acidIBA
05/2010 - 02/2008
5Therapeutic UsesIBA
09/2008 - 12/2004
5Type 1 Angiotensin ReceptorIBA
09/2007 - 03/2005
4Ranibizumab (Lucentis)FDA Link
10/2022 - 01/2019
4InterferonsIBA
01/2021 - 09/2006
4SolutionsIBA
01/2021 - 05/2002
4AntibodiesIBA
01/2016 - 07/2008
4Adrenal Cortex Hormones (Corticosteroids)IBA
08/2013 - 01/2007
4Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
04/2010 - 02/2004
4Analgesics (Analgesic Drugs)IBA
12/2007 - 03/2003
4EndotoxinsIBA
01/2007 - 08/2005
3Biomarkers (Surrogate Marker)IBA
03/2022 - 04/2006
3Biological ProductsIBA
10/2021 - 09/2007
3fibroblast growth factor 21IBA
10/2021 - 01/2019
3Neuroprotective AgentsIBA
01/2019 - 12/2006
3CholesterolIBA
06/2018 - 11/2004
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2016 - 05/2003
3N-Type Calcium Channels (N-Type Calcium Channel)IBA
08/2015 - 12/2014
3Peptides (Polypeptides)IBA
02/2013 - 06/2006
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
09/2008 - 04/2003
3Lysophosphatidic Acid ReceptorsIBA
02/2008 - 07/2004

Therapy/Procedure

50Vitrectomy
06/2022 - 02/2002
24Therapeutics
12/2021 - 04/2006
13Lasers (Laser)
12/2021 - 04/2002
9Traction
01/2018 - 11/2008
8Light Coagulation
11/2021 - 01/2008
6Immunotherapy
01/2020 - 09/2006
5Transjugular Intrahepatic Portasystemic Shunt
10/2014 - 01/2012
5Renal Dialysis (Hemodialysis)
02/2013 - 01/2002
5Cannula
04/2010 - 11/2004
4Kampo Medicine (Kampo)
06/2018 - 07/2002
4Surgical Instruments (Clip)
08/2013 - 11/2004
3Intravitreal Injections
01/2019 - 02/2004
3Operative Surgical Procedures
02/2018 - 05/2002
3Ligation
08/2015 - 12/2014
3Peritoneal Dialysis
01/2014 - 02/2007
3Intraocular Lenses (Intraocular Lens)
01/2014 - 10/2005
3Scleral Buckling
03/2008 - 02/2002